These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 16100213)
1. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Baughman RP; Lower EE; Bradley DA; Raymond LA; Kaufman A Chest; 2005 Aug; 128(2):1062-47. PubMed ID: 16100213 [TBL] [Abstract][Full Text] [Related]
2. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial. Bachelez H; van de Kerkhof PC; Strohal R; Kubanov A; Valenzuela F; Lee JH; Yakusevich V; Chimenti S; Papacharalambous J; Proulx J; Gupta P; Tan H; Tawadrous M; Valdez H; Wolk R; Lancet; 2015 Aug; 386(9993):552-61. PubMed ID: 26051365 [TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis. Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937 [TBL] [Abstract][Full Text] [Related]
4. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. Weinblatt ME; Kremer JM; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Fox RI; Jackson CG; Lange M; Burge DJ N Engl J Med; 1999 Jan; 340(4):253-9. PubMed ID: 9920948 [TBL] [Abstract][Full Text] [Related]
5. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223 [TBL] [Abstract][Full Text] [Related]
6. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. Gorman JD; Sack KE; Davis JC N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408 [TBL] [Abstract][Full Text] [Related]
7. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835 [TBL] [Abstract][Full Text] [Related]
8. A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial. Dougados M; Combe B; Braun J; Landewé R; Sibilia J; Cantagrel A; Feydy A; van der Heijde D; Leblanc V; Logeart I Ann Rheum Dis; 2010 Aug; 69(8):1430-5. PubMed ID: 20511606 [TBL] [Abstract][Full Text] [Related]
9. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Tyring S; Gottlieb A; Papp K; Gordon K; Leonardi C; Wang A; Lalla D; Woolley M; Jahreis A; Zitnik R; Cella D; Krishnan R Lancet; 2006 Jan; 367(9504):29-35. PubMed ID: 16399150 [TBL] [Abstract][Full Text] [Related]
10. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476 [TBL] [Abstract][Full Text] [Related]
11. Etanercept treatment for children and adolescents with plaque psoriasis. Paller AS; Siegfried EC; Langley RG; Gottlieb AB; Pariser D; Landells I; Hebert AA; Eichenfield LF; Patel V; Creamer K; Jahreis A; N Engl J Med; 2008 Jan; 358(3):241-51. PubMed ID: 18199863 [TBL] [Abstract][Full Text] [Related]
12. Etanercept in the treatment of palmoplantar pustulosis. Bissonnette R; Poulin Y; Bolduc C; Maari C; Provost N; Syrotuik J; Poulin-Costello CM; Nigen S J Drugs Dermatol; 2008 Oct; 7(10):940-6. PubMed ID: 19112757 [TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657 [TBL] [Abstract][Full Text] [Related]
14. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis. Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256 [TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis. Mease PJ; Woolley JM; Singh A; Tsuji W; Dunn M; Chiou CF J Rheumatol; 2010 Jun; 37(6):1221-7. PubMed ID: 20395648 [TBL] [Abstract][Full Text] [Related]
16. A randomized trial of etanercept as monotherapy for psoriasis. Gottlieb AB; Matheson RT; Lowe N; Krueger GG; Kang S; Goffe BS; Gaspari AA; Ling M; Weinstein GD; Nayak A; Gordon KB; Zitnik R Arch Dermatol; 2003 Dec; 139(12):1627-32; discussion 1632. PubMed ID: 14676082 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients. Tobinick E; Davoodifar S Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252 [TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled, trial of transforaminal epidural etanercept for the treatment of symptomatic lumbar disc herniation. Freeman BJ; Ludbrook GL; Hall S; Cousins M; Mitchell B; Jaros M; Wyand M; Gorman JR Spine (Phila Pa 1976); 2013 Nov; 38(23):1986-94. PubMed ID: 24165696 [TBL] [Abstract][Full Text] [Related]